Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 26,958 | 26,959 | 21,823 | 0.00 |
| Gross Profit | -26,958 | -26,959 | -21,823 | 0.00 |
| Selling General And Administration | 1.5M | 1.3M | 2.0M | 2.6M |
| General And Administrative Expense | 1.5M | 1.3M | 2.0M | 2.6M |
| Other Operating Expenses | 2.1M | 1.5M | 4.9M | 6.6M |
| Operating Expense | 3.5M | 2.9M | 6.9M | 9.2M |
| Operating Income | -3.6M | -2.9M | -6.9M | -9.2M |
| EBIT | -3.6M | -2.9M | -6.9M | -9.2M |
| Interest Income | 74,216 | 30,434 | 34,933 | 24,284 |
| Interest Income Non Operating | 74,216 | 30,434 | 34,933 | 24,284 |
| Net Interest Income | 74,216 | 30,434 | 34,933 | 24,284 |
| Other Income Expense | -3.4M | -1.4M | -657,703 | 3.6M |
| Other Non Operating Income Expenses | 366,371 | 216,806 | 770,944 | 4.1M |
| Special Income Charges | -3.7M | -1.9M | -765,559 | -47,001 |
| Write Off | 93,000 | 152,230 | 238,059 | 0.00 |
| Gain On Sale Of Security | 5,450 | 207,578 | -663,088 | -422,756 |
| Pretax Income | -6.9M | -4.3M | -7.6M | -5.5M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -6.9M | -4.3M | -7.6M | -5.5M |
| Net Income From Continuing Operation Net Minority Interest | -6.9M | -4.3M | -7.6M | -5.5M |
| Net Income Including Noncontrolling Interests | -6.9M | -4.3M | -7.6M | -5.5M |
| Net Income Common Stockholders | -6.9M | -4.3M | -7.6M | -5.5M |
| Net Income | -6.9M | -4.3M | -7.6M | -5.5M |
| EBITDA | -3.5M | -2.9M | -6.9M | -9.2M |
| Normalized EBITDA | 181,648 | -1.2M | -5.5M | -8.7M |
| Reconciled Depreciation | 26,958 | 26,959 | 21,823 | 0.00 |
| Basic EPS | -0.14 | -0.21 | -0.42 | -0.42 |
| Diluted EPS | -0.14 | -0.21 | -0.42 | -0.42 |
| Basic Average Shares | 47.6M | 20.5M | 18.0M | 13.6M |
| Diluted Average Shares | 47.6M | 20.5M | 18.0M | 13.6M |
| Total Unusual Items | -3.7M | -1.7M | -1.4M | -469,757 |
| Total Unusual Items Excluding Goodwill | -3.7M | -1.7M | -1.4M | -469,757 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -3.1M | -2.6M | -6.1M | -5.0M |
| Diluted NI Availto Com Stockholders | -6.9M | -4.3M | -7.6M | -5.5M |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 |
| Impairment Of Capital Assets | 3.6M | 1.7M | 527,500 | 47,001 |
| Net Income Continuous Operations | -6.9M | -4.3M | -7.6M | -5.5M |
| Net Non Operating Interest Income Expense | 74,216 | 30,434 | 34,933 | 24,284 |
| Other Gand A | 925,884 | 1.0M | 1.6M | 1.3M |
| Reconciled Cost Of Revenue | 26,958 | 26,959 | 21,823 | 0.00 |
| Rent And Landing Fees | 40,424 | 27,907 | 32,890 | 19,662 |
| Rent Expense Supplemental | 40,424 | 27,907 | 32,890 | 19,662 |
| Salaries And Wages | 524,730 | 276,536 | 404,679 | 1.3M |
| Total Expenses | 3.6M | 2.9M | 6.9M | 9.2M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 1.2M | 460,002 | 887,341 | 3.6M |
| Cash Cash Equivalents And Short Term Investments | 1.2M | 528,264 | 2.6M | 6.6M |
| Cash Financial | -- | -- | 887,341 | 3.6M |
| Other Short Term Investments | 7,731 | 68,262 | 1.8M | 3.0M |
| Accounts Receivable | 279,668 | 427,897 | -- | 0.00 |
| Receivables | 279,668 | 427,897 | 303,988 | 544,534 |
| Prepaid Assets | 28,313 | 305,083 | 351,234 | 433,116 |
| Current Assets | 1.5M | 1.3M | 3.3M | 7.6M |
| Net PPE | 5.1M | 6.5M | 7.8M | 6.4M |
| Investments And Advances | 37,500 | 37,500 | 37,500 | 37,500 |
| Total Non Current Assets | 5.1M | 6.5M | 7.9M | 6.4M |
| Total Assets | 6.7M | 7.8M | 11.2M | 14.0M |
| Current Debt | -- | 101,625 | -- | -- |
| Current Debt And Capital Lease Obligation | -- | 101,625 | -- | -- |
| Accounts Payable | 107,691 | 199,693 | 624,402 | 495,321 |
| Payables | 107,691 | 199,693 | 624,402 | 495,321 |
| Payables And Accrued Expenses | 107,691 | 199,693 | 624,402 | 495,321 |
| Other Current Liabilities | 14,991 | 202,790 | 69,033 | 522,991 |
| Current Liabilities | 122,682 | 504,108 | 693,435 | 1.0M |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 122,682 | 504,108 | 693,435 | 1.0M |
| Common Stock | 53.8M | 48.3M | 47.4M | 43.0M |
| Capital Stock | 53.8M | 48.3M | 47.4M | 43.0M |
| Retained Earnings | -56.6M | -49.7M | -45.4M | -37.9M |
| Gains Losses Not Affecting Retained Earnings | 9.3M | 8.8M | 8.5M | 7.9M |
| Common Stock Equity | 6.5M | 7.3M | 10.5M | 13.0M |
| Stockholders Equity | 6.5M | 7.3M | 10.5M | 13.0M |
| Total Equity Gross Minority Interest | 6.5M | 7.3M | 10.5M | 13.0M |
| Total Capitalization | 6.5M | 7.3M | 10.5M | 13.0M |
| Net Tangible Assets | 6.5M | 7.3M | 10.5M | 13.0M |
| Tangible Book Value | 6.5M | 7.3M | 10.5M | 13.0M |
| Working Capital | 1.4M | 757,136 | 2.6M | 6.5M |
| Invested Capital | 6.5M | 7.4M | 10.5M | 13.0M |
| Total Debt | -- | 101,625 | -- | -- |
| Share Issued | 57.3M | 21.2M | 19.2M | 16.0M |
| Ordinary Shares Number | 57.3M | 21.2M | 19.2M | 16.0M |
| Current Notes Payable | 0.00 | 101,625 | 0.00 | -- |
| Held To Maturity Securities | 37,500 | 37,500 | 37,500 | 37,500 |
| Investmentin Financial Assets | 37,500 | 37,500 | 37,500 | 37,500 |
| Other Receivables | -- | 353,774 | -- | -- |
| Taxes Receivable | -- | 74,123 | 303,988 | 544,534 |
| Treasury Shares Number | -- | 0.00 | -- | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -2.7M | -3.2M | -6.3M | -7.4M |
| Cash Flow From Continuing Operating Activities | -2.7M | -3.2M | -6.3M | -7.4M |
| Depreciation And Amortization | 26,958 | 26,959 | 21,823 | 0.00 |
| Depreciation Amortization Depletion | 26,958 | 26,959 | 21,823 | 0.00 |
| Stock Based Compensation | 524,730 | 276,536 | 404,679 | 1.3M |
| Change In Working Capital | 239,997 | -654,697 | 213,450 | -108,047 |
| Change In Receivables | 148,229 | -276,139 | 2,487 | -131,527 |
| Change In Payables And Accrued Expense | -92,002 | -424,709 | 129,081 | 375,521 |
| Other Non Cash Items | -366,371 | -216,806 | -753,566 | -3.6M |
| Capital Expenditure | -127,546 | -320,000 | -349,861 | -423,300 |
| Purchase Of PPE | -127,546 | -320,000 | -349,861 | -423,300 |
| Net PPE Purchase And Sale | -102,546 | -320,000 | -349,861 | -423,300 |
| Purchase Of Investment | -- | -- | -- | 0.00 |
| Sale Of Investment | 65,421 | 1.9M | 602,524 | 558,517 |
| Net Investment Purchase And Sale | 65,421 | 1.9M | 602,524 | 558,517 |
| Investing Cash Flow | -37,125 | 1.6M | 252,663 | 135,217 |
| Cash Flow From Continuing Investing Activities | -37,125 | 1.6M | 252,663 | 135,217 |
| Issuance Of Debt | -- | 101,625 | 0.00 | -- |
| Net Issuance Payments Of Debt | -101,625 | 101,625 | 0.00 | -- |
| Issuance Of Capital Stock | 3.7M | 1.1M | 3.5M | 7.7M |
| Net Common Stock Issuance | 3.7M | 1.1M | 3.5M | 7.7M |
| Financing Cash Flow | 3.5M | 1.2M | 3.3M | 8.0M |
| Cash Flow From Continuing Financing Activities | 3.5M | 1.2M | 3.3M | 8.0M |
| Changes In Cash | 745,975 | -427,339 | -2.7M | 706,514 |
| Beginning Cash Position | 460,002 | 887,341 | 3.6M | 2.9M |
| End Cash Position | 1.2M | 460,002 | 887,341 | 3.6M |
| Free Cash Flow | -2.8M | -3.5M | -6.6M | -7.9M |
| Interest Paid Supplemental Data | -- | -- | 0.00 | 0.00 |
| Amortization Cash Flow | -- | -- | 21,823 | 0.00 |
| Amortization Of Intangibles | -- | -- | 21,823 | 0.00 |
| Asset Impairment Charge | 3.7M | 1.9M | 765,559 | 47,001 |
| Change In Prepaid Assets | 183,770 | 46,151 | 81,882 | -352,041 |
| Common Stock Issuance | 3.7M | 1.1M | 3.5M | 7.7M |
| Depreciation | 26,958 | 26,959 | 21,823 | -- |
| Gain Loss On Investment Securities | -4,890 | -- | -- | 39,483 |
| Net Income From Continuing Operations | -6.9M | -4.3M | -7.6M | -5.5M |
| Net Other Financing Charges | -67,640 | -34,098 | -129,000 | -180,308 |
| Net Short Term Debt Issuance | -101,625 | 101,625 | 0.00 | -- |
| Operating Gains Losses | -4,890 | -- | -- | 39,483 |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | 470,279 |
| Sale Of PPE | 25,000 | 0.00 | -- | 0.00 |
| Short Term Debt Issuance | -- | 101,625 | 0.00 | -- |
| Unrealized Gain Loss On Investment Securities | 0.00 | -208,877 | 659,390 | 379,217 |